Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Ista Surges After Agreeing to Be Acquired by Bausch & Lomb
FDAnews Drug Daily Bulletin
March 28, 2012
| Vol. 9 No. 62
Ista Surges After Agreeing to Be Acquired by Bausch & Lomb
Ista Pharmaceuticals, the maker of eye medications, rose 7.8 percent after agreeing to be bought by Bausch & Lomb for $500 million.
Bloomberg
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
The Buzz
FDA Studying Composite Score Effect On DTC Marketing
FDA Hydrocodone Decision Delay Reflects Enforcement, Access Tensions
Biosimilar Interchangeability Battle Moves to California